blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3190123

EP3190123 - IMPROVED LOV-D ACYLTRANSFERASE MEDIATED ACYLATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 28.03.2026
FormerThe patent has been granted
Status updated on  21.06.2019
FormerGrant of patent is intended
Status updated on  27.02.2019
FormerExamination is in progress
Status updated on  29.06.2018
FormerRequest for examination was made
Status updated on  19.01.2018
FormerThe application has been published
Status updated on  15.06.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063 / US
[2017/28]
Inventor(s)01 / COLLIER, Steven James
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
03-15/24 The Galen 117525 / SG
02 / TEO, Ee Ling
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
03-15/24 The Galen 117525 / SG
03 / SUKUMARAN, Joly
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
03-15/24 The Galen 117525 / SG
04 / WILSON, Robert John
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
03-15/24 The Galen 117525 / SG
05 / XU, Junye
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
03-15/24 The Galen 117525 / SG
 [2019/30]
Former [2017/28]01 / COLLIER, Steven James
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
117525 03-15/24 The Galen / SG
02 / TEO, Ee Ling
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
117525 03-15/24 The Galen / SG
03 / SUKUMARAN, Joly
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
117525 03-15/24 The Galen / SG
04 / WILSON, Robert John
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
117525 03-15/24 The Galen / SG
05 / XU, Junye
Codexis Laboratories Singapore Pte Ltd
61 Science Park Road
117525 03-15/24 The Galen / SG
Representative(s)Chapman, Desmond Mark
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2017/28]
Application number, filing date16201269.424.09.2010
[2017/28]
Priority number, dateUS20090247274P30.09.2009         Original published format: US 247274 P
US20090247253P30.09.2009         Original published format: US 247253 P
[2017/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3190123
Date:12.07.2017
Language:EN
[2017/28]
Type: B1 Patent specification 
No.:EP3190123
Date:24.07.2019
Language:EN
[2019/30]
Search report(s)(Supplementary) European search report - dispatched on:EP28.03.2017
ClassificationIPC:C07K14/00, C12N9/10, C12P7/00
[2017/28]
CPC:
C12P17/06 (EP,US); C07K14/00 (US); C12N15/52 (EP,US);
C12N9/1025 (US); C12N9/1029 (EP,US); C12P7/62 (EP,US);
C12Y203/01 (EP,US); Y02P20/52 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2018/08]
Former [2017/28]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERBESSERTE DURCH LOV-D-ACYLTRANSFERASE VERMITTELTE ACYLIERUNG[2017/28]
English:IMPROVED LOV-D ACYLTRANSFERASE MEDIATED ACYLATION[2017/28]
French:ACYLATION À MÉDIATION ACYLTRANSFÉRASE LOV-D AMÉLIORÉE[2017/28]
Examination procedure29.11.2016Date on which the examining division has become responsible
12.01.2018Amendment by applicant (claims and/or description)
12.01.2018Examination requested  [2018/08]
02.07.2018Despatch of a communication from the examining division (Time limit: M04)
17.08.2018Reply to a communication from the examining division
28.02.2019Communication of intention to grant the patent
14.06.2019Fee for grant paid
14.06.2019Fee for publishing/printing paid
14.06.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10821066.7  / EP2483293
Opposition(s)03.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
29.11.2016Renewal fee patent year 03
29.11.2016Renewal fee patent year 04
29.11.2016Renewal fee patent year 05
29.11.2016Renewal fee patent year 06
29.11.2016Renewal fee patent year 07
27.09.2017Renewal fee patent year 08
27.09.2018Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL24.07.2019
AT24.07.2019
CY24.07.2019
CZ24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
MK24.07.2019
MT24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
LU24.09.2019
BE30.09.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
[2022/32]
Former [2021/34]AL24.07.2019
AT24.07.2019
CY24.07.2019
CZ24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
MT24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
LU24.09.2019
BE30.09.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2021/26]AL24.07.2019
AT24.07.2019
CY24.07.2019
CZ24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
LU24.09.2019
BE30.09.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/37]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
SI24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
LU24.09.2019
BE30.09.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/36]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
LU24.09.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/35]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
LU24.09.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
PT25.11.2019
IS24.02.2020
Former [2020/27]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
SK24.07.2019
SM24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
PT25.11.2019
IS24.02.2020
Former [2020/25]AL24.07.2019
AT24.07.2019
CZ24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
SK24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
PT25.11.2019
IS24.02.2020
Former [2020/24]AL24.07.2019
AT24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
MC24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
PT25.11.2019
IS24.02.2020
Former [2020/23]AL24.07.2019
AT24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
IT24.07.2019
LT24.07.2019
LV24.07.2019
PL24.07.2019
RO24.07.2019
SE24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/22]AL24.07.2019
AT24.07.2019
EE24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
SE24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/17]AL24.07.2019
AT24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
SE24.07.2019
TR24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/15]AL24.07.2019
AT24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
SE24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/12]AT24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
SE24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
IS24.11.2019
PT25.11.2019
Former [2020/11]AT24.07.2019
ES24.07.2019
FI24.07.2019
HR24.07.2019
LT24.07.2019
LV24.07.2019
SE24.07.2019
BG24.10.2019
NO24.10.2019
GR25.10.2019
PT25.11.2019
Former [2020/10]AT24.07.2019
FI24.07.2019
LT24.07.2019
SE24.07.2019
BG24.10.2019
NO24.10.2019
PT25.11.2019
Former [2020/09]FI24.07.2019
LT24.07.2019
NO24.10.2019
Former [2020/08]LT24.07.2019
NO24.10.2019
Documents cited:Search[YA] US2003208046  (HUNTER CHRISTIE L et al.)
 [Y] US2009191602  (TANG YI et al.)
 [A] US5917058  (KUMAR YATENDRA et al.)
 [Y] US6063919  (GAUDIOSO LARRY A et al.)
 [YA]   XINKAI XIE ET AL: "Rational improvement of simvastatin synthase solubility in Escherichia coli to higher whole-cell biocatalystic activity", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, vol. 102, no. 1, 1 January 2009 (2009-01-01), pages 20 - 28, XP008154987, ISSN: 0006-3592, DOI: 10.1002/BIT.22028

DOI:   http://dx.doi.org/10.1002/bit.22028
by applicantUS6391583
 WO2007139871
 WO2005040107
 WO9426920
 US24725309
 US4444784
 US4582915
 US5393893
 US5763646
 US5763653
 EP0299656
 WO9945003
 WO0037692
   T. G. SCHIMMEL, APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 1307 - 1311
   BIOTECHNOL BIOENG, vol. 102, no. L, 1 January 2009 (2009-01-01), pages 20 - 28
   A. W. ALBERTS, J, PROC. NATL. ACAD. SCI. U.S.A., vol. 77, 1980, pages 3957 - 3961
   A. ENDO, J. ANTIBIOT., vol. 33, 1980, pages 334 - 336
   J. K. CHAN, J. AM. CHEM. SOC., vol. 105, 1983, pages 3334 - 3336
   Y. YOSHIZAWA, J. AM. CHEM. SOC., vol. 116, 1994, pages 2693 - 2694
   XIE ET AL.: "Biosynthesis of Lovastatin Analogs with a Broadly Specific Acyltransferase", CHEM. BIOL., vol. 13, 2006, pages 1161 - 1169
   BIOTECHNOL BIOENG, vol. 102, no. 1, 1 January 2009 (2009-01-01), pages 20 - 28
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.